Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
127.9 USD | +3.31% | -3.81% | +17.32% |
01/07 | Merck, Orion Convert Ongoing Collaboration Into Exclusive Global License for Opevesostat | MT |
01/07 | Merck: license agreement with Orion Corp. for opevesostat | CF |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+17.32% | 314B | |
+56.86% | 815B | |
+43.90% | 641B | |
-6.57% | 352B | |
+9.94% | 303B | |
+16.08% | 242B | |
+2.29% | 224B | |
+13.96% | 218B | |
+7.98% | 168B | |
-1.98% | 159B |
- Stock Market
- Equities
- MRK Stock
- News Merck & Co., Inc.
- Tranche Update on Merck & Co., Inc.'s Equity Buyback Plan announced on October 25, 2018.